Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study - Concepedia

Concepedia

Publication | Closed Access

Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study

419

Citations

17

References

2015

Year

Signe Vedel‐Krogh, Sune F. Nielsen, Peter Lange, Jørgen Vestbo, Børge G. Nordestgaard

American Journal of Respiratory and Critical Care Medicine

Abstract

Among individuals with COPD in the general population, increased blood eosinophil levels above 0.34 × 10(9) cells per liter were associated with a 1.76-fold increased risk of severe exacerbations.

References

	Year	Citations
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Rafael Lozano, Mohsen Naghavi, Kyle J Foreman, The Lancet	2012	14.1K
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease TERENCE A. R. SEEMUNGAL, Gavin C. Donaldson, Elizabeth Paul, American Journal of Respiratory and Critical Care Medicine	1998	2.3K
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Mona Bafadhel, Susan McKenna, Sarah Terry, American Journal of Respiratory and Critical Care Medicine	2011	1K
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials Steven Pascoe, Nicholas Locantore, Mark T. Dransfield, The Lancet Respiratory Medicine Blood Eosinophil CountsAllergyInflammatory Lung DiseaseAdvanced Lung DiseaseControlled Trials	2015	722
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial Lisa Davies, RM Angus, P. M. A. Calverley The Lancet Pulmonary CarePulmonary MedicineOral CorticosteroidsMedicinePulmonary Disease	1999	595
Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease Mona Bafadhel, Susan McKenna, Sarah Terry, American Journal of Respiratory and Critical Care Medicine	2012	593
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial Christopher E. Brightling, William Monteiro, Richard J. Ward, The Lancet AsthmaAdvanced Lung DiseaseImmunologySputum EosinophiliaEosinophilic Disorder	2000	590
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease Pier Luigi Paggiaro, Ragnar Dahle, I Bakran, The Lancet AllergyAdvanced Lung DiseaseClinical TrialsPlacebo-controlled TrialInhaled Fluticasone Propionate	1998	509
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Roshan Siva, R. H. Green, Christopher E. Brightling, European Respiratory Journal InflammationAllergyInflammatory Lung DiseaseLung InflammationRespiratory Diseases	2007	448
Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease Jörg D. Leuppi, Philipp Schüetz, Roland Bingisser, JAMA	2013	421

Page 1